Bui AN, Bougrine A, Buchbinder EI, Giobbie-Hurder A, et al. Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study. J Am Acad Dermatol 2021 Jul 9. pii: S0190-9622(21)02087.
PMID: 34252467